サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1472214

組織学・細胞学市場：試験タイプ別、製品別、検査タイプ別、用途別、エンドユーザー別：世界の機会分析と産業予測、2023～2032年

Histology and Cytology Market By Type of Examination, By Product, By Test Type, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

出版日
ページ情報
英文 298 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
組織学・細胞学市場：試験タイプ別、製品別、検査タイプ別、用途別、エンドユーザー別：世界の機会分析と産業予測、2023～2032年
出版日: 2024年02月01日
発行: Allied Market Research
ページ情報: 英文 298 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の組織学・細胞学市場は、2022年に72億米ドルとなり、2023年から2032年にかけて11.9%のCAGRで成長し、2032年までには222億米ドルに達すると予測されています。

組織学と細胞学はヘルスケア分野で不可欠な分析技術であり、多様な病状の診断と治療管理において極めて重要な意義を持っています。組織学は組織の顕微鏡検査を含み、その構造的特徴を精査し、異常を特定します。一方、細胞学は個々の細胞の検査に集中し、異常や疾患を特定します。これらの診断手法は、がん、感染症、その他の病的状態を適時に特定する上で重要な役割を果たしています。

がんなどの慢性疾患の有病率の上昇とヘルスケア・インフラの改善は、組織診および細胞診市場の成長を促進すると予想されています。例えば、米国がん協会によると、2020年には全世界で推定1,930万人の新規がん患者（非黒色腫皮膚がんを除く1,810万人）と約1,000万人のがん死亡者（非黒色腫皮膚がんを除く990万人）が発生すると報告されています。がん、心血管疾患、呼吸器疾患などの慢性疾患の顕著な増加により、高度な診断法とスクリーニング法が急務となっています。

組織学および細胞学的検査は、悪性腫瘍に関連する細胞および組織レベルの変化に関する貴重な洞察を提供し、正確な診断と個別化された治療戦略の策定に役立ちます。さらに、世界の高齢化の進行に伴い、慢性疾患の発生率も増加し、疾病診断のための組織・細胞診の需要がさらに高まっています。

さらに、ヘルスケア専門家や患者の意識の高まりが、組織学的・細胞学的検査の需要促進に重要な役割を果たしています。患者は、がんや感染症を含むさまざまな病状の診断における組織診や細胞診の重要性をますます認識するようになっており、これがこれらの診断技術に対する需要の高まりにつながっています。さらに、ヘルスケア専門家も、正確でタイムリーな診断を提供する組織診および細胞診の利点をより認識するようになっています。医学研究と技術の進歩により、ヘルスケア専門家はこれらの診断ツールの重要性を理解し、臨床診療に取り入れることができるようになりました。このように、ヘルスケア専門家と患者の間での意識の高まりが、市場の成長を促進すると予想されます。

さらに、新興諸国におけるヘルスケアインフラの改善も市場の成長を促進すると予想されます。新興諸国では、ヘルスケアシステムの改善に向けた投資が進んでいるため、組織学や細胞学など、疾患の発見と管理に重要な役割を果たす高度な診断技術に対する需要が急増しています。例えば、国立医学図書館による2023年の報告書によると、2022会計年度の時点で、インドでは2,000以上の公的医療施設が報告されています。病院、診断研究所、研究センターなどのヘルスケア施設の拡大と近代化は、最先端の組織学・細胞学技術を採用するための強固なエコシステムを構築しています。このように、ヘルスケアインフラの改善は市場の成長に大きく寄与すると予想されます。

組織学・細胞学市場は、検査タイプ、製品、検査タイプ、用途、エンドユーザー、地域によって区分されます。検査タイプ別では、市場は組織診と細胞診に二分されます。製品別では、市場は機器と分析ソフトウェアシステム、消耗品と試薬に分類されます。検査タイプ別では、市場は顕微鏡法、フローサイトメトリー法、分子遺伝学的手法に分けられます。

利害関係者にとっての主なメリット

  • 当レポートは、2022年から2032年までの組織検査・細胞診市場分析の市場セグメント、現在の動向、推定動向、ダイナミクスを定量的に分析し、組織学・細胞学市場の有力な市場機会を特定します。
  • 市場促進要因、市場抑制要因、市場機会に関連する情報とともに市場調査を提供します。
  • ポーターのファイブフォース分析では、利害関係者が利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるよう、バイヤーとサプライヤーの潜在力を明らかにします。
  • 組織学・細胞学市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
  • 各地域の主要国は、世界市場への収益貢献度に応じてマッピングされています。
  • 市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
  • 本レポートには、地域別および世界の組織学・細胞学市場の動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析が含まれています。

その他の特典は以下の通りです：

  • 四半期ごとの最新情報（コーポレートライセンスでのみご利用いただけます）
  • 購入前または購入後に、ご希望の企業プロファイルを5社追加で無料アップデート。
  • 5ユーザーライセンスおよびエンタープライズユーザーライセンス購入の場合、次期バージョンを無料で提供。
  • アナリストによる16時間のサポート（購入後、レポートのレビューで追加データ要件が見つかった場合、質問や販売後の問い合わせを解決するためにアナリストによる16時間のサポートを受けることができます）
  • 15%の無料カスタマイズ（レポートの調査範囲またはセグメントがお客様の要件に一致しない場合、15%は3営業日の無料作業に相当します）
  • 5ユーザーライセンスおよびエンタープライズユーザーライセンスの無料データパック。（エクセル版レポート）
  • レポートが6ヶ月から12ヶ月以上前の場合、更新レポートを無料で提供。
  • 24時間優先対応
  • 業界の最新情報とホワイトペーパーを無料で提供。
    Histology and Cytology Market-IMG1
  • レポートカスタマイズの可能性（追加費用とタイムラインに関しましては販売担当へご連絡ください）
  • クライアントの関心に応じた企業プロファイルの追加
  • 企業プロファイルの拡張リスト
  • 過去の市場データ

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主要な影響要因
    • 主要な投資機会
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
      • アジア太平洋における製薬産業の成長
      • 慢性疾患の急増
      • ヘルスケアインフラの改善
    • 抑制要因
      • 組織学的・細胞学的分析機器の高コスト
    • 機会
      • 組織学的・細胞学的分析技術の技術的進歩

第4章 組織学・細胞学市場：試験タイプ別

  • 概要
  • 組織学
  • 細胞学

第5章 組織学・細胞学市場：製品別

  • 概要
  • 装置・分析ソフトウェアシステム
  • 消耗品と試薬

第6章 組織学・細胞学市場：検査タイプ別

  • 概要
  • 顕微鏡検査法
  • フローサイトメトリー法
  • 分子遺伝学的検査法

第7章 組織学・細胞学市場：用途別

  • 概要
  • 創薬・薬剤設計
  • 臨床診断
  • 学術研究

第8章 組織学・細胞学市場：エンドユーザー別

  • 概要
  • 製薬企業・バイオテクノロジー企業
  • CDMO
  • 診断研究所
  • その他

第9章 組織学・細胞学市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • コロンビア
    • アルゼンチン
    • その他ラテンアメリカ
  • 中東・アフリカ
    • GCC
    • 南アフリカ
    • 北アフリカ
    • その他中東・アフリカ

第10章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング、2022年

第11章 企業プロファイル

  • Hologic, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Becton, Dickinson, and Company
  • Danaher Corporation
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Sysmex Corporation
  • Trivitron Healthcare Private Limited
  • Koninklijke Philips N.V.
図表

LIST OF TABLES

  • TABLE 01. GLOBAL HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 02. HISTOLOGY AND CYTOLOGY MARKET FOR HISTOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. HISTOLOGY AND CYTOLOGY MARKET FOR CYTOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. GLOBAL HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 05. HISTOLOGY AND CYTOLOGY MARKET FOR INSTRUMENTS AND ANALYSIS SOFTWARE SYSTEM, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. HISTOLOGY AND CYTOLOGY MARKET FOR CONSUMABLE AND REAGENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. GLOBAL HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 08. HISTOLOGY AND CYTOLOGY MARKET FOR MICROSCOPY METHODS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. HISTOLOGY AND CYTOLOGY MARKET FOR FLOW CYTOMETRY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. HISTOLOGY AND CYTOLOGY MARKET FOR MOLECULAR GENETIC METHODS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 12. HISTOLOGY AND CYTOLOGY MARKET FOR DRUG DISCOVERY AND DESIGNING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. HISTOLOGY AND CYTOLOGY MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. HISTOLOGY AND CYTOLOGY MARKET FOR ACADEMIC RESEARCH, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 16. HISTOLOGY AND CYTOLOGY MARKET FOR PHARMA AND BIOTECH COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. HISTOLOGY AND CYTOLOGY MARKET FOR CDMO, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. HISTOLOGY AND CYTOLOGY MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. HISTOLOGY AND CYTOLOGY MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. HISTOLOGY AND CYTOLOGY MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 22. NORTH AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 26. NORTH AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 27. U.S. HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 28. U.S. HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 29. U.S. HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 30. U.S. HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 31. U.S. HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 32. CANADA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 33. CANADA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 34. CANADA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 35. CANADA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 36. CANADA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 37. MEXICO HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 38. MEXICO HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 39. MEXICO HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 40. MEXICO HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 41. MEXICO HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 43. EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 44. EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 45. EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 46. EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 47. EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 48. GERMANY HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 49. GERMANY HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 50. GERMANY HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 51. GERMANY HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 52. GERMANY HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 53. FRANCE HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 54. FRANCE HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 55. FRANCE HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 56. FRANCE HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 57. FRANCE HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 58. UK HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 59. UK HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 60. UK HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 61. UK HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 62. UK HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 63. ITALY HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 64. ITALY HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 65. ITALY HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 66. ITALY HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 67. ITALY HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. SPAIN HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 69. SPAIN HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 70. SPAIN HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 71. SPAIN HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 72. SPAIN HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 73. REST OF EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 74. REST OF EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 75. REST OF EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 76. REST OF EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 77. REST OF EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 78. ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 79. ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 80. ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 81. ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 82. ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 83. ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 84. JAPAN HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 85. JAPAN HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 86. JAPAN HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 87. JAPAN HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 88. JAPAN HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 89. CHINA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 90. CHINA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 91. CHINA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 92. CHINA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 93. CHINA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 94. INDIA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 95. INDIA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 96. INDIA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 97. INDIA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 98. INDIA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 99. AUSTRALIA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 100. AUSTRALIA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 101. AUSTRALIA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 102. AUSTRALIA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 103. AUSTRALIA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 104. SOUTH KOREA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 105. SOUTH KOREA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 106. SOUTH KOREA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 107. SOUTH KOREA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 108. SOUTH KOREA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 109. REST OF ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 110. REST OF ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 111. REST OF ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 112. REST OF ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 113. REST OF ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 114. LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 115. LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 116. LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 117. LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 118. LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 119. LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 120. BRAZIL HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 121. BRAZIL HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 122. BRAZIL HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 123. BRAZIL HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 124. BRAZIL HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 125. COLOMBIA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 126. COLOMBIA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 127. COLOMBIA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 128. COLOMBIA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 129. COLOMBIA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 130. ARGENTINA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 131. ARGENTINA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 132. ARGENTINA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 133. ARGENTINA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 134. ARGENTINA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 135. REST OF LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 136. REST OF LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 137. REST OF LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 138. REST OF LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 139. REST OF LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 140. MIDDLE EAST AND AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 141. MIDDLE EAST AND AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 142. MIDDLE EAST AND AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 143. MIDDLE EAST AND AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 144. MIDDLE EAST AND AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 145. MIDDLE EAST AND AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 146. GCC HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 147. GCC HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 148. GCC HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 149. GCC HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 150. GCC HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 151. SOUTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 152. SOUTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 153. SOUTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 154. SOUTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 155. SOUTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 156. NORTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 157. NORTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 158. NORTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 159. NORTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 160. NORTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 161. REST OF MEA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 162. REST OF MEA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 163. REST OF MEA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 164. REST OF MEA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 165. REST OF MEA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 166. HOLOGIC, INC.: KEY EXECUTIVES
  • TABLE 167. HOLOGIC, INC.: COMPANY SNAPSHOT
  • TABLE 168. HOLOGIC, INC.: PRODUCT SEGMENTS
  • TABLE 169. HOLOGIC, INC.: PRODUCT PORTFOLIO
  • TABLE 170. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
  • TABLE 171. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • TABLE 172. F. HOFFMANN-LA ROCHE LTD.: PRODUCT SEGMENTS
  • TABLE 173. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
  • TABLE 174. F. HOFFMANN-LA ROCHE LTD.: KEY STRATERGIES
  • TABLE 175. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 176. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 177. ABBOTT LABORATORIES: PRODUCT SEGMENTS
  • TABLE 178. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 179. BECTON, DICKINSON, AND COMPANY: KEY EXECUTIVES
  • TABLE 180. BECTON, DICKINSON, AND COMPANY: COMPANY SNAPSHOT
  • TABLE 181. BECTON, DICKINSON, AND COMPANY: PRODUCT SEGMENTS
  • TABLE 182. BECTON, DICKINSON, AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 183. BECTON, DICKINSON, AND COMPANY: KEY STRATERGIES
  • TABLE 184. DANAHER CORPORATION: KEY EXECUTIVES
  • TABLE 185. DANAHER CORPORATION: COMPANY SNAPSHOT
  • TABLE 186. DANAHER CORPORATION: PRODUCT SEGMENTS
  • TABLE 187. DANAHER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 188. MERCK KGAA: KEY EXECUTIVES
  • TABLE 189. MERCK KGAA: COMPANY SNAPSHOT
  • TABLE 190. MERCK KGAA: PRODUCT SEGMENTS
  • TABLE 191. MERCK KGAA: PRODUCT PORTFOLIO
  • TABLE 192. THERMO FISHER SCIENTIFIC, INC.: KEY EXECUTIVES
  • TABLE 193. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • TABLE 194. THERMO FISHER SCIENTIFIC, INC.: PRODUCT SEGMENTS
  • TABLE 195. THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
  • TABLE 196. SYSMEX CORPORATION: KEY EXECUTIVES
  • TABLE 197. SYSMEX CORPORATION: COMPANY SNAPSHOT
  • TABLE 198. SYSMEX CORPORATION: PRODUCT SEGMENTS
  • TABLE 199. SYSMEX CORPORATION: PRODUCT PORTFOLIO
  • TABLE 200. TRIVITRON HEALTHCARE PRIVATE LIMITED: KEY EXECUTIVES
  • TABLE 201. TRIVITRON HEALTHCARE PRIVATE LIMITED: COMPANY SNAPSHOT
  • TABLE 202. TRIVITRON HEALTHCARE PRIVATE LIMITED: PRODUCT SEGMENTS
  • TABLE 203. TRIVITRON HEALTHCARE PRIVATE LIMITED: PRODUCT PORTFOLIO
  • TABLE 204. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
  • TABLE 205. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • TABLE 206. KONINKLIJKE PHILIPS N.V.: SERVICE SEGMENTS
  • TABLE 207. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. HISTOLOGY AND CYTOLOGY MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF HISTOLOGY AND CYTOLOGY MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN HISTOLOGY AND CYTOLOGY MARKET (2022 TO 2032)
  • FIGURE 04. TOP INVESTMENT POCKETS IN HISTOLOGY AND CYTOLOGY MARKET (2023-2032)
  • FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. LOW THREAT OF NEW ENTRANTS
  • FIGURE 07. LOW THREAT OF SUBSTITUTES
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. LOW BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL HISTOLOGY AND CYTOLOGY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR HISTOLOGY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR CYTOLOGY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR INSTRUMENTS AND ANALYSIS SOFTWARE SYSTEM, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR CONSUMABLE AND REAGENTS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR MICROSCOPY METHODS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR FLOW CYTOMETRY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR MOLECULAR GENETIC METHODS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR DRUG DISCOVERY AND DESIGNING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR ACADEMIC RESEARCH, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 25. HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 26. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR PHARMA AND BIOTECH COMPANIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 27. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR CDMO, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 28. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 29. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 30. HISTOLOGY AND CYTOLOGY MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 31. U.S. HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. CANADA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. MEXICO HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. GERMANY HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. FRANCE HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. UK HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. ITALY HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. SPAIN HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. REST OF EUROPE HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. JAPAN HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. CHINA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. INDIA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. AUSTRALIA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. SOUTH KOREA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. REST OF ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. BRAZIL HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 47. COLOMBIA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 48. ARGENTINA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 49. REST OF LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 50. GCC HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 51. SOUTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 52. NORTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 53. REST OF MEA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 54. TOP WINNING STRATEGIES, BY YEAR (2021-2023)
  • FIGURE 55. TOP WINNING STRATEGIES, BY DEVELOPMENT (2021-2023)
  • FIGURE 56. TOP WINNING STRATEGIES, BY COMPANY (2021-2023)
  • FIGURE 57. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 58. COMPETITIVE DASHBOARD
  • FIGURE 59. COMPETITIVE HEATMAP: HISTOLOGY AND CYTOLOGY MARKET
  • FIGURE 60. TOP PLAYER POSITIONING, 2022
  • FIGURE 61. HOLOGIC, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 62. HOLOGIC, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 63. HOLOGIC, INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 64. F. HOFFMANN-LA ROCHE LTD.: SALES REVENUE, 2020-2022 ($MILLION)
  • FIGURE 65. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 66. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 67. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 68. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 69. BECTON, DICKINSON, AND COMPANY: NET REVENUE, 2021-2023 ($MILLION)
  • FIGURE 70. BECTON, DICKINSON, AND COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 71. BECTON, DICKINSON, AND COMPANY: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 72. DANAHER CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 73. DANAHER CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 74. DANAHER CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 75. MERCK KGAA: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 76. MERCK KGAA: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 77. MERCK KGAA: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 78. THERMO FISHER SCIENTIFIC, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 79. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 80. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 81. SYSMEX CORPORATION: NET REVENUE, 2021-2023 ($MILLION)
  • FIGURE 82. SYSMEX CORPORATION: REVENUE SHARE BY REGION, 2023 (%)
  • FIGURE 83. KONINKLIJKE PHILIPS N.V.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 84. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 85. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY REGION, 2022 (%)
目次
Product Code: A15397

The global histology and cytology market was valued at $7.2 billion in 2022, and is projected to reach $22.2 billion by 2032, growing at a CAGR of 11.9% from 2023 to 2032.

Histology and cytology constitute indispensable analytical techniques in the healthcare sector, holding a pivotal significance in the diagnosis and therapeutic management of diverse medical conditions. Histology entails the microscopic examination of tissues, scrutinizing their structural characteristics and identifying anomalies, whereas cytology concentrates on the examination of individual cells to identify abnormalities or diseases. These diagnostic methodologies play a critical role in the timely identification of cancer, infectious diseases, and other pathological conditions.

The rise in prevalence of chronic diseases such as cancer and the improving healthcare infrastructure is expected to drive the growth of the histology and cytology market. For instance, according to the American Cancer Society, it was reported that in 2020, Worldwide, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020. The notable increase in chronic conditions, such as cancer, cardiovascular diseases, and respiratory disorders, has created a pressing need for advanced diagnostic and screening methods.

Histology and cytology procedures provide invaluable insights into the cellular and tissue-level changes associated with malignancies, aiding in accurate diagnosis and the formulation of personalized treatment strategies. Moreover, as the aging population continues to grow worldwide, there is an inherent increase in the incidence of chronic diseases, further driving the demand for histology and cytology for disease diagnosis.

In addition, surge in awareness among healthcare professionals and patients plays a crucial role in driving the demand for histological and cytological examinations, as individuals become more proactive in managing their health and seeking early detection of diseases. Patients increasingly recognize the importance of histology and cytology in diagnosing various medical conditions, including cancers and infectious diseases, which has led to a rising demand for these diagnostic technologies. Moreover, healthcare professionals have become more aware of the benefits of histology and cytology in providing accurate and timely diagnoses. With advancements in medical research and technology, healthcare professionals are better equipped to understand the significance of these diagnostic tools and incorporate them into their clinical practices. Thus, the rise in awareness among the healthcare professionals and patients is expected to drive the growth of the market.

Furthermore, the improving healthcare infrastructure in developing countries is expected to drive the growth of the market. As countries across the developing regions progressively invest in upgrading their healthcare systems, there is a surge in demand for advanced diagnostic techniques, such as histology and cytology, which play a crucial role in disease detection and management. For instance, according to the 2023 report by National Library of Medicine, it was reported that over two lakh public health facilities were reported in India as of the financial year 2022. The expansion and modernization of healthcare facilities, including hospitals, diagnostic laboratories, and research centers, are creating a robust ecosystem for the adoption of cutting-edge histology and cytology technologies. Thus, the improving healthcare infrastructure is expected to significantly contribute to the growth of the market.

The histology and cytology market is segmented on the basis of type of examination, product, test type, application, end user, and region. On the basis of type of examination, the market is bifurcated into histology and cytology. On the basis of product, the market is classified into instruments and analysis software system and consumable and reagents. On the basis of test type, the market is divided into microscopy methods, flow cytometry, and molecular genetic methods.

On the basis of application, the market is segregated into drug discovery and designing, clinical diagnostics, and academic research. On the basis of end user, the market is fragmented into pharma & biotech companies, CDMO, diagnostic laboratories, and others. Others include hospital and academic research. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Major key players that operate in the histology and cytology market are Hologic, Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Becton, Dickinson and Company, Danaher Corporation, Merck KGaA, Thermo Fisher Scientific, Inc., Sysmex Corporation, Trivitron Healthcare Private Limited, and Koninklijke Philips N.V.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the histology and cytology market analysis from 2022 to 2032 to identify the prevailing histology and cytology market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the histology and cytology market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global histology and cytology market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.
    Histology and Cytology Market - IMG1
  • Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Type of Examination

  • Histology
  • Cytology

By Product

  • Instruments and Analysis Software System
  • Consumable and Reagents

By Test Type

  • Microscopy Methods
  • Flow Cytometry
  • Molecular Genetic Methods

By Application

  • Drug Discovery and Designing
  • Clinical Diagnostics
  • Academic Research

By End User

  • Pharma and Biotech Companies
  • CDMO
  • Diagnostic Laboratories
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Colombia
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • Gcc
    • South Africa
    • North Africa
    • Rest Of Mea

Key Market Players:

    • Abbott Laboratories
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Trivitron Healthcare Private Limited
    • Koninklijke Philips N.V.
    • F. Hoffmann-La Roche Ltd.
    • Danaher Corporation
    • Sysmex Corporation
    • Becton, Dickinson, and Company
    • Hologic, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Low intensity of rivalry
    • 3.3.5. Low bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Growing Pharmaceutical Industry in Asia Pacific Region.
      • 3.4.1.2. Surge in prevalence of chronic diseases.
      • 3.4.1.3. Improving Healthcare Infrastructure.
    • 3.4.2. Restraints
      • 3.4.2.1. High cost of histological and cytological analytical instruments.
    • 3.4.3. Opportunities
      • 3.4.3.1. Technological advancement in the histological and cytological analysis technology.

CHAPTER 4: HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Histology
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Cytology
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Instruments and Analysis Software System
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Consumable and Reagents
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country

CHAPTER 6: HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Microscopy Methods
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Flow Cytometry
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Molecular Genetic Methods
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Drug Discovery and Designing
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Clinical Diagnostics
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Academic Research
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country

CHAPTER 8: HISTOLOGY AND CYTOLOGY MARKET, BY END USER

  • 8.1. Overview
    • 8.1.1. Market size and forecast
  • 8.2. Pharma and Biotech Companies
    • 8.2.1. Key market trends, growth factors and opportunities
    • 8.2.2. Market size and forecast, by region
    • 8.2.3. Market share analysis by country
  • 8.3. CDMO
    • 8.3.1. Key market trends, growth factors and opportunities
    • 8.3.2. Market size and forecast, by region
    • 8.3.3. Market share analysis by country
  • 8.4. Diagnostic Laboratories
    • 8.4.1. Key market trends, growth factors and opportunities
    • 8.4.2. Market size and forecast, by region
    • 8.4.3. Market share analysis by country
  • 8.5. Others
    • 8.5.1. Key market trends, growth factors and opportunities
    • 8.5.2. Market size and forecast, by region
    • 8.5.3. Market share analysis by country

CHAPTER 9: HISTOLOGY AND CYTOLOGY MARKET, BY REGION

  • 9.1. Overview
    • 9.1.1. Market size and forecast By Region
  • 9.2. North America
    • 9.2.1. Key market trends, growth factors and opportunities
    • 9.2.2. Market size and forecast, by Type of Examination
    • 9.2.3. Market size and forecast, by Product
    • 9.2.4. Market size and forecast, by Test Type
    • 9.2.5. Market size and forecast, by Application
    • 9.2.6. Market size and forecast, by End User
    • 9.2.7. Market size and forecast, by country
      • 9.2.7.1. U.S.
      • 9.2.7.1.1. Market size and forecast, by Type of Examination
      • 9.2.7.1.2. Market size and forecast, by Product
      • 9.2.7.1.3. Market size and forecast, by Test Type
      • 9.2.7.1.4. Market size and forecast, by Application
      • 9.2.7.1.5. Market size and forecast, by End User
      • 9.2.7.2. Canada
      • 9.2.7.2.1. Market size and forecast, by Type of Examination
      • 9.2.7.2.2. Market size and forecast, by Product
      • 9.2.7.2.3. Market size and forecast, by Test Type
      • 9.2.7.2.4. Market size and forecast, by Application
      • 9.2.7.2.5. Market size and forecast, by End User
      • 9.2.7.3. Mexico
      • 9.2.7.3.1. Market size and forecast, by Type of Examination
      • 9.2.7.3.2. Market size and forecast, by Product
      • 9.2.7.3.3. Market size and forecast, by Test Type
      • 9.2.7.3.4. Market size and forecast, by Application
      • 9.2.7.3.5. Market size and forecast, by End User
  • 9.3. Europe
    • 9.3.1. Key market trends, growth factors and opportunities
    • 9.3.2. Market size and forecast, by Type of Examination
    • 9.3.3. Market size and forecast, by Product
    • 9.3.4. Market size and forecast, by Test Type
    • 9.3.5. Market size and forecast, by Application
    • 9.3.6. Market size and forecast, by End User
    • 9.3.7. Market size and forecast, by country
      • 9.3.7.1. Germany
      • 9.3.7.1.1. Market size and forecast, by Type of Examination
      • 9.3.7.1.2. Market size and forecast, by Product
      • 9.3.7.1.3. Market size and forecast, by Test Type
      • 9.3.7.1.4. Market size and forecast, by Application
      • 9.3.7.1.5. Market size and forecast, by End User
      • 9.3.7.2. France
      • 9.3.7.2.1. Market size and forecast, by Type of Examination
      • 9.3.7.2.2. Market size and forecast, by Product
      • 9.3.7.2.3. Market size and forecast, by Test Type
      • 9.3.7.2.4. Market size and forecast, by Application
      • 9.3.7.2.5. Market size and forecast, by End User
      • 9.3.7.3. UK
      • 9.3.7.3.1. Market size and forecast, by Type of Examination
      • 9.3.7.3.2. Market size and forecast, by Product
      • 9.3.7.3.3. Market size and forecast, by Test Type
      • 9.3.7.3.4. Market size and forecast, by Application
      • 9.3.7.3.5. Market size and forecast, by End User
      • 9.3.7.4. Italy
      • 9.3.7.4.1. Market size and forecast, by Type of Examination
      • 9.3.7.4.2. Market size and forecast, by Product
      • 9.3.7.4.3. Market size and forecast, by Test Type
      • 9.3.7.4.4. Market size and forecast, by Application
      • 9.3.7.4.5. Market size and forecast, by End User
      • 9.3.7.5. Spain
      • 9.3.7.5.1. Market size and forecast, by Type of Examination
      • 9.3.7.5.2. Market size and forecast, by Product
      • 9.3.7.5.3. Market size and forecast, by Test Type
      • 9.3.7.5.4. Market size and forecast, by Application
      • 9.3.7.5.5. Market size and forecast, by End User
      • 9.3.7.6. Rest of Europe
      • 9.3.7.6.1. Market size and forecast, by Type of Examination
      • 9.3.7.6.2. Market size and forecast, by Product
      • 9.3.7.6.3. Market size and forecast, by Test Type
      • 9.3.7.6.4. Market size and forecast, by Application
      • 9.3.7.6.5. Market size and forecast, by End User
  • 9.4. Asia-Pacific
    • 9.4.1. Key market trends, growth factors and opportunities
    • 9.4.2. Market size and forecast, by Type of Examination
    • 9.4.3. Market size and forecast, by Product
    • 9.4.4. Market size and forecast, by Test Type
    • 9.4.5. Market size and forecast, by Application
    • 9.4.6. Market size and forecast, by End User
    • 9.4.7. Market size and forecast, by country
      • 9.4.7.1. Japan
      • 9.4.7.1.1. Market size and forecast, by Type of Examination
      • 9.4.7.1.2. Market size and forecast, by Product
      • 9.4.7.1.3. Market size and forecast, by Test Type
      • 9.4.7.1.4. Market size and forecast, by Application
      • 9.4.7.1.5. Market size and forecast, by End User
      • 9.4.7.2. China
      • 9.4.7.2.1. Market size and forecast, by Type of Examination
      • 9.4.7.2.2. Market size and forecast, by Product
      • 9.4.7.2.3. Market size and forecast, by Test Type
      • 9.4.7.2.4. Market size and forecast, by Application
      • 9.4.7.2.5. Market size and forecast, by End User
      • 9.4.7.3. India
      • 9.4.7.3.1. Market size and forecast, by Type of Examination
      • 9.4.7.3.2. Market size and forecast, by Product
      • 9.4.7.3.3. Market size and forecast, by Test Type
      • 9.4.7.3.4. Market size and forecast, by Application
      • 9.4.7.3.5. Market size and forecast, by End User
      • 9.4.7.4. Australia
      • 9.4.7.4.1. Market size and forecast, by Type of Examination
      • 9.4.7.4.2. Market size and forecast, by Product
      • 9.4.7.4.3. Market size and forecast, by Test Type
      • 9.4.7.4.4. Market size and forecast, by Application
      • 9.4.7.4.5. Market size and forecast, by End User
      • 9.4.7.5. South Korea
      • 9.4.7.5.1. Market size and forecast, by Type of Examination
      • 9.4.7.5.2. Market size and forecast, by Product
      • 9.4.7.5.3. Market size and forecast, by Test Type
      • 9.4.7.5.4. Market size and forecast, by Application
      • 9.4.7.5.5. Market size and forecast, by End User
      • 9.4.7.6. Rest of Asia-Pacific
      • 9.4.7.6.1. Market size and forecast, by Type of Examination
      • 9.4.7.6.2. Market size and forecast, by Product
      • 9.4.7.6.3. Market size and forecast, by Test Type
      • 9.4.7.6.4. Market size and forecast, by Application
      • 9.4.7.6.5. Market size and forecast, by End User
  • 9.5. Latin America
    • 9.5.1. Key market trends, growth factors and opportunities
    • 9.5.2. Market size and forecast, by Type of Examination
    • 9.5.3. Market size and forecast, by Product
    • 9.5.4. Market size and forecast, by Test Type
    • 9.5.5. Market size and forecast, by Application
    • 9.5.6. Market size and forecast, by End User
    • 9.5.7. Market size and forecast, by country
      • 9.5.7.1. Brazil
      • 9.5.7.1.1. Market size and forecast, by Type of Examination
      • 9.5.7.1.2. Market size and forecast, by Product
      • 9.5.7.1.3. Market size and forecast, by Test Type
      • 9.5.7.1.4. Market size and forecast, by Application
      • 9.5.7.1.5. Market size and forecast, by End User
      • 9.5.7.2. Colombia
      • 9.5.7.2.1. Market size and forecast, by Type of Examination
      • 9.5.7.2.2. Market size and forecast, by Product
      • 9.5.7.2.3. Market size and forecast, by Test Type
      • 9.5.7.2.4. Market size and forecast, by Application
      • 9.5.7.2.5. Market size and forecast, by End User
      • 9.5.7.3. Argentina
      • 9.5.7.3.1. Market size and forecast, by Type of Examination
      • 9.5.7.3.2. Market size and forecast, by Product
      • 9.5.7.3.3. Market size and forecast, by Test Type
      • 9.5.7.3.4. Market size and forecast, by Application
      • 9.5.7.3.5. Market size and forecast, by End User
      • 9.5.7.4. Rest of Latin America
      • 9.5.7.4.1. Market size and forecast, by Type of Examination
      • 9.5.7.4.2. Market size and forecast, by Product
      • 9.5.7.4.3. Market size and forecast, by Test Type
      • 9.5.7.4.4. Market size and forecast, by Application
      • 9.5.7.4.5. Market size and forecast, by End User
  • 9.6. Middle East and Africa
    • 9.6.1. Key market trends, growth factors and opportunities
    • 9.6.2. Market size and forecast, by Type of Examination
    • 9.6.3. Market size and forecast, by Product
    • 9.6.4. Market size and forecast, by Test Type
    • 9.6.5. Market size and forecast, by Application
    • 9.6.6. Market size and forecast, by End User
    • 9.6.7. Market size and forecast, by country
      • 9.6.7.1. Gcc
      • 9.6.7.1.1. Market size and forecast, by Type of Examination
      • 9.6.7.1.2. Market size and forecast, by Product
      • 9.6.7.1.3. Market size and forecast, by Test Type
      • 9.6.7.1.4. Market size and forecast, by Application
      • 9.6.7.1.5. Market size and forecast, by End User
      • 9.6.7.2. South Africa
      • 9.6.7.2.1. Market size and forecast, by Type of Examination
      • 9.6.7.2.2. Market size and forecast, by Product
      • 9.6.7.2.3. Market size and forecast, by Test Type
      • 9.6.7.2.4. Market size and forecast, by Application
      • 9.6.7.2.5. Market size and forecast, by End User
      • 9.6.7.3. North Africa
      • 9.6.7.3.1. Market size and forecast, by Type of Examination
      • 9.6.7.3.2. Market size and forecast, by Product
      • 9.6.7.3.3. Market size and forecast, by Test Type
      • 9.6.7.3.4. Market size and forecast, by Application
      • 9.6.7.3.5. Market size and forecast, by End User
      • 9.6.7.4. Rest Of Mea
      • 9.6.7.4.1. Market size and forecast, by Type of Examination
      • 9.6.7.4.2. Market size and forecast, by Product
      • 9.6.7.4.3. Market size and forecast, by Test Type
      • 9.6.7.4.4. Market size and forecast, by Application
      • 9.6.7.4.5. Market size and forecast, by End User

CHAPTER 10: COMPETITIVE LANDSCAPE

  • 10.1. Introduction
  • 10.2. Top winning strategies
  • 10.3. Product mapping of top 10 player
  • 10.4. Competitive dashboard
  • 10.5. Competitive heatmap
  • 10.6. Top player positioning, 2022

CHAPTER 11: COMPANY PROFILES

  • 11.1. Hologic, Inc.
    • 11.1.1. Company overview
    • 11.1.2. Key executives
    • 11.1.3. Company snapshot
    • 11.1.4. Operating business segments
    • 11.1.5. Product portfolio
    • 11.1.6. Business performance
  • 11.2. F. Hoffmann-La Roche Ltd.
    • 11.2.1. Company overview
    • 11.2.2. Key executives
    • 11.2.3. Company snapshot
    • 11.2.4. Operating business segments
    • 11.2.5. Product portfolio
    • 11.2.6. Business performance
    • 11.2.7. Key strategic moves and developments
  • 11.3. Abbott Laboratories
    • 11.3.1. Company overview
    • 11.3.2. Key executives
    • 11.3.3. Company snapshot
    • 11.3.4. Operating business segments
    • 11.3.5. Product portfolio
    • 11.3.6. Business performance
  • 11.4. Becton, Dickinson, and Company
    • 11.4.1. Company overview
    • 11.4.2. Key executives
    • 11.4.3. Company snapshot
    • 11.4.4. Operating business segments
    • 11.4.5. Product portfolio
    • 11.4.6. Business performance
    • 11.4.7. Key strategic moves and developments
  • 11.5. Danaher Corporation
    • 11.5.1. Company overview
    • 11.5.2. Key executives
    • 11.5.3. Company snapshot
    • 11.5.4. Operating business segments
    • 11.5.5. Product portfolio
    • 11.5.6. Business performance
  • 11.6. Merck KGaA
    • 11.6.1. Company overview
    • 11.6.2. Key executives
    • 11.6.3. Company snapshot
    • 11.6.4. Operating business segments
    • 11.6.5. Product portfolio
    • 11.6.6. Business performance
  • 11.7. Thermo Fisher Scientific, Inc.
    • 11.7.1. Company overview
    • 11.7.2. Key executives
    • 11.7.3. Company snapshot
    • 11.7.4. Operating business segments
    • 11.7.5. Product portfolio
    • 11.7.6. Business performance
  • 11.8. Sysmex Corporation
    • 11.8.1. Company overview
    • 11.8.2. Key executives
    • 11.8.3. Company snapshot
    • 11.8.4. Operating business segments
    • 11.8.5. Product portfolio
    • 11.8.6. Business performance
  • 11.9. Trivitron Healthcare Private Limited
    • 11.9.1. Company overview
    • 11.9.2. Key executives
    • 11.9.3. Company snapshot
    • 11.9.4. Operating business segments
    • 11.9.5. Product portfolio
  • 11.10. Koninklijke Philips N.V.
    • 11.10.1. Company overview
    • 11.10.2. Key executives
    • 11.10.3. Company snapshot
    • 11.10.4. Operating business segments
    • 11.10.5. Product portfolio
    • 11.10.6. Business performance